跳至主要内容
临床试验/NL-OMON30991
NL-OMON30991已完成不适用

Glycocalyx measurements in premature atherosclerosis - Glycocalyx measurements in premature atherosclerosis

Academisch Ziekenhuis Maastricht0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - a cardiac, cerebral or peripheral vascular disease before the age of 40
  • - a positive family history for cardiovascular disease, defined as a first degree family member with a cardiovascular event before the age of 55 for men and 60 for women. Furthermore, they should be between the age of 35 and 55 years old.
  • -Controls will be defined as healthy in case they have no cardiovascular history, such as no cardiac, cerebrovascular or peripheral artery disease and no complaints of angina, claudication or TIA and no family history for cardiovascular disease. Furthermore, they should be between the age of 35 and 55 years old.

排除标准

  • - a positive history for hypertension or diabetes mellitus
  • - pregnancy or lactating women
  • - subjects below the age of 18
  • - unable to give informed consent
  • Diseases mentioned at the inclusioncriteria.

研究者

相似试验